William Towner
Kaiser Permanente(US)
Publications by Year
Research Areas
HIV/AIDS drug development and treatment, HIV/AIDS Research and Interventions, HIV Research and Treatment, HIV-related health complications and treatments, Hepatitis C virus research
Most-Cited Works
- → Remdesivir for 5 or 10 Days in Patients with Severe Covid-19(2020)1,431 cited
- → Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection(2015)1,110 cited
- → Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection(2015)845 cited
- → Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016(2020)589 cited
- → Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1(2015)465 cited
- → Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care(2016)436 cited
- → Efficacy and safety of TMC125 (etravirine) in treatment-experienced HIV-1-infected patients in DUET-2: 24-week results from a randomised, double-blind, placebo-controlled trial(2007)392 cited
- → All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study(2014)343 cited
- → HIV infection and the risk of cancers with and without a known infectious cause(2009)299 cited
- → HIV Infection, Immunodeficiency, Viral Replication, and the Risk of Cancer(2011)283 cited